Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-13 Sale | 2024-02-15 5:27 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 1,352 | $132.85 | $179,612 | 85,552 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 7:12 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 2,260 | $138.73 | $313,530 | 30,314 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:00 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 1,283 | $140.72 | $180,539 | 28,284 (Direct) | View |
| 2023-08-21 Sale | 2023-08-23 7:58 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 2,132 | $107.39 | $228,958 | 27,131 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 7:16 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 28,588 | $102.61 | $2,933,470 | 25,213 (Direct) | View |
| 2023-01-31 Sale | 2023-02-02 4:53 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 1,283 | $109.98 | $141,108 | 21,357 (Direct) | View |
| 2022-02-07 Sale | 2022-02-09 6:51 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 4,290 | $80.53 | $345,486 | 20,204 (Direct) | View |
| 2021-12-01 Sale | 2021-12-03 5:02 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 1,645 | $82.59 | $135,852 | 16,349 (Direct) | View |
| 2021-02-08 Sale | 2021-02-09 9:30 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 2,910 | $116.82 | $339,942 | 66,940 (Direct) | View |
| 2020-12-01 Sale | 2020-12-02 4:12 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 1,645 | $94.66 | $155,721 | 11,494 (Direct) | View |
| 2020-11-12 Sale | 2020-11-16 6:02 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 2,257 | $90.74 | $204,810 | 10,014 (Direct) | View |
| 2020-08-05 Sale | 2020-08-07 6:22 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 2,257 | $118.9 | $268,356 | 7,983 (Direct) | View |
| 2020-05-07 Sale | 2020-05-11 8:17 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 15,000 | $110.21 | $1,653,134 | 50,953 (Direct) | View |
| 2020-04-28 Sale | 2020-04-30 4:25 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 1,741 | $102.49 | $178,435 | 5,953 (Direct) | View |
| 2020-04-24 Sale | 2020-04-28 8:32 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 1,934 | $99.52 | $192,467 | 7,694 (Direct) | View |
| 2020-02-07 Sale | 2020-02-11 7:06 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 2,030 | $103.35 | $209,807 | 5,701 (Direct) | View |
| 2019-12-02 Sale | 2019-12-04 6:06 pm | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 1,645 | $116.33 | $191,360 | 3,876 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-13 Option Award | 2024-02-15 5:27 pm | N/A 2034-02-13 | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 54,024 | $0 | 85,552 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:04 pm | N/A 2033-02-13 | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 74,053 | $0 | 74,053 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 7:54 pm | N/A 2032-01-31 | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 76,107 | $0 | 76,107 (Direct) | View |
| 2021-02-08 Option Award(A) | 2021-03-26 9:48 pm | N/A 2031-02-08 | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 49,049 | $0 | 49,049 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-09 9:30 pm | N/A 2031-02-08 | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 52,071 | $0 | 66,940 (Direct) | View |
| 2020-05-07 Exercise | 2020-05-11 8:17 pm | N/A 2027-12-01 | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 15,000 | $73.6 | 50,953 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 6:40 pm | N/A 2030-02-06 | NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer | 71,066 | $0 | 71,066 (Direct) | View |